Acute coronary syndrome: Biochemical strategies in the troponin era

Chest

Volumn 122, Issue 4, 2002, Pages 1428-1435

  Panteghini, Mauro ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

Emergency medicine; Laboratory diagnosis; Myocardial infarction; Myoglobin; Troponin

Indexed keywords

BIOCHEMICAL MARKER; PROTEIN; TROPONIN;

COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; LABORATORY TEST; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; THORAX PAIN;

EID: 0036430291     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.4.1428     Document Type: Review

References (69)

1. Kahn SE. The challenge of evaluating the patient with chest pain. Arch Pathol Lab Med 2000; 124:1418-1419
2. Lee TH, Goldman L. Evaluation of the patient with acute chest pain. N Engl J Med 2000; 342:1187-1195
3. Mathew TP, Menown IBA, Adgey AAJ. Optimizing classification of acute myocardial infarction: from diagnosis to prognosis. Eur Heart J 1999; 20:1146-1148
4. Nomenclature and criteria for diagnosis of ischemic heart disease: report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation 1979; 59:607-608
5. Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA 2000; 283:3223-3229
6. Rouan GW, Lee TH, Cook EF, et al. Clinical characteristics and outcome of acute myocardial infarction in patients with initially normal or nonspecific electrocardiograms: a report from the Multicenter Chest Pain Study. Am J Cardiol 1989; 64:1087-1092
7. Panteghini M. Biochemical assessment of myocardial damage with new diagnostic tools. Cardiologia 1999; 44:419-425
8. Kontos MC, Jesse RL. Evaluation of the emergency department chest pain patients. Am J Cardiol 2000; 85:32B-39B
9. Lee TH, Rouan GW, Weisberg MC, et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol 1987; 60:219-224
10. Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000; 342:1163-1170
11. Panteghini M, Apple FS, Christenson RH, et al. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. Clin Chem Lab Med 1999; 37:687-693
12. Alpert J, Thygesen K, for the Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 2000; 36:959-969
13. Jaffe AS, Ravkilde J, Roberts R, et al. It's time for a change to a troponin standard. Circulation 2000; 102:1216-1220
14. Bodor GS, Survant L, Voss EM, et al. Cardiac troponin T composition in normal and regenerating human skeletal muscle. Clin Chem 1997; 43:476-484
15. Wu AHB, Feng YJ. Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes. Eur Heart J 1998; 19(suppl N):N25-N29
16. Apple FS, Murakami M, Panteghini M, et al. International survey on the use of cardiac markers. Clin Chem 2001; 47:587-588
17. Wu AHB, Apple FS, Gibler WB, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45:1104-1121
18. Panteghini M, Pagani F, Bonetti G, et al. Single-point troponin T measurement on the day of coronary unit discharge after myocardial infarction strongly correlates with ejection fraction and infarct size by nuclear imaging and with CK-MB release [abstract]. Clin Chem 2001; 47(suppl):A195
19. Panteghini M, Pagani F, Bonetti G, et al. Cardiac biochemical algorithms in the troponin era: audit of some care maps one year after their introduction. Biochim Clin 2000; 24:469-475
20. Panteghini M. Diagnostic application of CK-MB mass determination. Clin Chim Acta 1998; 272:23-31
21. Panteghini M, Pagani F, Bonetti G. The sensitivity of cardiac markers: an evidence-based approach. Clin Chem Lab Med 1999; 37:1097-1106
22. Christenson RH, Duh SH. Evidence based approach to practice guides and decision thresholds for cardiac markers. Scand J Clin Lab Invest 1999; 59(suppl 230):90-102
23. Zaninotto M, Altinier S, Lachin M, et al. Strategies for the early diagnosis of acute myocardial infarction using biochemical markers. Am J Clin Pathol 1999; 111:399-405
24. Caragher TE, Fernandez BB, Barr LA. Long-term experience with an accelerated protocol for diagnosis of chest pain. Arch Pathol Lab Med 2000; 124:1434-1439
25. Owen A, Khan W, Griffiths KD. Troponin T: role in altering patient management and enabling earlier discharge from a district general hospital. Ann Clin Biochem 2001; 38:135-139
26. Möckel M, Gerhardt W, Heller G Jr., et al. Validation of NACB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes. Clin Chim Acta 2001; 303:167-179
27. Panteghini M. Biochemical markers of cardiac damage: what is current, what is redundant? Biochim Clin 2000; 24:431-438
28. Bholasingh R, De Winter RJ, Nieuwenhuijs AB, et al. Rate of inaccurate estimation of interval between onset of symptoms and admission in patients with acute myocardial infarction. Copenhagen, Denmark: Proceedings of The Challenge of Acute Coronary Syndromes; The Lancet Conference, 1999; 7
29. Jesse RL. Myocardial necrosis in "pure unstable angina": identification of high-risk subgroups or a contradiction in terms? Am Heart J 1999; 137:190-192
30. Lindahl B, Venge P, Wallentin L, for the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93:1651-1657
31. Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000; 343:1139-1147
32. Lindahl B, Diderholm E, Lagerqvist B, et al. Troponin T 0.1 μg/L is an inappropriate cut-off value for risk stratification in unstable coronary artery disease using the new third generation troponin T assay [abstract]. Eur Heart J 2000; 21(suppl):522
33. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335:1342-1349
34. Morrow DA, Rifai N, Tanasijevic MJ, et al. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11B substudy. Clin Chem 2000; 46:453-460
35. Meier MA, Al-Badr WH, Cooper JV, et al. The new definition of myocardial infarction: what does it mean clinically [abstract]? J Am Coll Cardiol 2001; 37:310A
36. Goodman S, Johnson J, Sullivan C, et al. What is an MI? Prospective analysis of the diagnostic and prognostic impact of adding troponins to the definition of myocardial infarction [abstract]. J Am Coll Cardiol 2001; 37:358A
37. Johari V, Davis GK, Hoybook K, et al. Retrospective database review for the use of cardiac troponin I for detection of myocardial infarction [abstract]. Clin Chem 2001; 47(suppl):A212
38. PetitClerc C, Solberg HE. IFCC approved recommendation (1987) on the theory of reference values: part 2; selection of individuals for the production of reference values. Clin Chim Acta 1987; 170:S3-S12
39. Solberg HE. IFCC approved recommendation (1987) on the theory of reference values: part 5; statistical treatment of collected reference values: determination of reference limits. J Clin Chem Clin Biochem1987; 25:645-656
40. Apple FS. Clinical and analytical standardization issues confronting cardiac troponin I. Clin Chem 1999; 45:18-20
41. Ravkilde J. Risk stratification in acute coronary syndrome using cardiac troponin I. Clin Chem 2000; 46:443-444
42. Apple FS, Wu AHB. Myocardial infarction redefined: role of cardiac troponin testing. Clin Chem 2001; 47:377-379
43. Panteghini M. Recent approaches to the standardization of cardiac markers. Scand J Clin Lab Invest 2001; 61:95-102
44. Panteghini M. Present issues in the determination of troponins and other markers of cardiac damage. Clin Biochem 2000; 33:161-166
45. Panteghini M, Gerhardt W, Apple FS, et al. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001; 39:174-178
46. Apple FS, Maturen AJ, Mullins RE, et al. Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem 1999; 45:206-212
47. Pagani F, Bonetti G, Stefini F, et al. Determination of decision limits for ACS:Systems cardiac troponin I. Clin Chem Lab Med 2000; 38:1155-1157
48. Stiegler H, Fisher Y, Vazquez-Jimenez JF, et al. Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem 2000; 46:1338-1344
49. Wu AHB. Laboratory and near patient testing for cardiac markers. J Clin Ligand Assay 1999; 22:32-37
50. Wu A, Apple F, Venge P, et al. Analytical performance of Beckman Coulter's Access AccuTnI (troponin I) in a multi-center evaluation [abstract]. Clin Chem Lab Med 2001; 39(suppl):S191
51. Bataillon S, Incaurgarat B, Varret F, et al. Preliminary evaluation of the Vidas cardiac troponin I assay [abstract]. Clin Chem Lab Med 2001; 39(suppl):S195
52. Kaminski D, Sivakoff S, McCormack B, et al. Development and analytical performance of an improved method for cardiac troponin-I on the Dade Behring Dimension clinical chemistry system [abstract]. Clin Chem 2001; 47(suppl):A211
53. Kao JT, Wong IL, Lee JY, et al. Comparison of Abbott AxSYM, Behring Opus Plus, DPC Immulite and Ortho-Clinical Diagnostics Vitroc ECi for measurement of cardiac troponin I. Ann Clin Biochem 2001; 38:140-146
54. Altinier S, Mion M, Cappelletti C, et al. Rapid measurement of cardiac markers on Stratus CS. Clin Chem 2000; 46:991-993
55. Apple FS, Anderson FP, Collinson P, et al. Clinical evaluation of the First Medical whole blood, point-of-care testing device for detection of myocardial infarction. Clin Chem 2000; 46:1604-1609
56. Apple FS, Koplen B, Murakami MM. Preliminary evaluation of the Vitros ECi cardiac troponin I assay. Clin Chem 2000; 46:572-574
57. Muller-Bardorff M, Rauscher T, Kampmann M, et al. Quantitative bedside assay for cardiac troponin T: a complementary method to centralized laboratory testing. Clin Chem 1999; 45:1002-1008
58. Pagani F, Bonetti G, Panteghini M. Evaluation of the Elecsys electrochemiluminescent immunoassay for cardiac troponin T determination [abstract]. Clin Chem 1999; 45(suppl):A144
59. Yeo KTJ, Quinn-Hall KS, Bateman SW, et al. Functional sensitivity of cardiac troponin assays and its implications for risk stratification for patients with acute coronary syndromes. In: Adams JE III, Apple FS, Jaffe AS, et al, eds. Markers in cardiology: current and future clinical applications. Armonk, NY: Futura Publishing, 2001; 23-29
60. Hafner G, Peetz D, Dati F, et al. Analytical and clinical evaluation of troponin I determination on Dimension RXL-HM. Clin Chem Lab Med 2000; 38:355-361
61. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac troponin T for standardization of third generation troponin T methods. Scand J Clin Lab Invest 1999; 59(suppl 230):128-131
62. Ohman E, Armstrong P, Christenson R, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators. N Engl J Med 1996; 335:1333-1341
63. Stubbs P, Collinson P, Moseley D, et al. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation 1996; 94:1291-1297
64. Ohman EM, Armstrong PW, White HD, et al. Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. Am J Cardiol 1999; 84:1281-1286
65. Lindahl B. Therapeutic implications of the use of cardiac markers in acute coronary syndromes. Scand J Clin Lab Invest 1999; 259(suppl 230):43-49
66. Matetzky S, Sharir T, Domingo M, et al. Elevated troponin I level on admission is associated with adverse outcome of primary angioplasty in acute myocardial infarction. Circulation 2000; 102:1611-1616
67. Giannitsis E, Lehrke S, Wiegand KH, et al. Risk stratification in patients with inferior acute myocardial infarction treated by percutaneous coronary interventions: the role of admission troponin T. Circulation 2000; 102:2038-2044
68. Apple FS. Biochemical markers of thrombolytic success. Scand J Clin Lab Invest 1999; 259(suppl 230):60-66
69. Jaffe AS. 2001: a biomarker odyssey. Clin Chim Acta 1999: 284:197-211